About Darrin M. Disley

Have started, grown and/or invested in >40 life science, technology and social enterprises closing c$550M financing and c$700M in commercial deals. Follow on Twitter @DarrinMDisley

Currently CEO of and Investor in Mogrify Ltd a UK biotechnology company aiming to transform the development of cell therapies using a systematic direct cell conversion & maintenance platform powered by big-data. Follow on Twitter @Mogrify_UK

Co-founder, investor and former CEO of gene editing company Horizon Discovery Group Plc (LSE: HZD) leading company from $200k seed-funding to a 2.5X oversubscribed $113M life science IPO on AIM and onto a peak market capitalization in excess of $550M. Follow on Twitter @HorizonGenomics

Co-founder, investor and former Chairman of GeoSpock Ltd a U.K. tech company with a mission to bring contextual understanding to the everything connected world. Follow on Twitter @GeoSpock

Avid believer in developing entrepreneurial talent supporting business plan competition and providing non-dilutive funding and mentoring programs via a 10 year endowment of the C R Lowe Carpe Diem Enterprise Fund. Projects supported recently include Cambridge University Entrepreneurs, GeoSpock Ltd, HealX Ltd, Footprint Cafes CIO, MPhil in Bioscience Enterprise (Cambridge University) and SimPrints Ltd.

Recognition (selected):

Officer of the Most Excellent Order of the British Empire

Lifetime Queens Award for Enterprise Promotion

European Life Science Business Leader of the Year

UK Quoted Company Entrepreneur of Year

UK Public Life Science CEO of Year

Barclays Iconic UK Male Entrepreneur

Scrip Awards
Best Licensing Deal
Executive of Year

Business Excellence Awards
Business Person of Year

Times/Maserati 100 Disruptive UK Entrepreneurs

Cambridge’s 25 Most Influential

100 Faces of a Vibrant UK Economy

Royal Society of Chemistry
175 Faces of Chemistry